Cipla (CIPLA) — Announcement

📢 Key Event
USFDA inspection of InvaGen subsidiary completed with one Form 483 observation

💡 Investor Takeaway
The inspection outcome poses minimal immediate risk as the company plans to resolve the observation promptly.

⚠️ Risks
Potential regulatory scrutiny of manufacturing operations

Cipla announced a USFDA inspection of its InvaGen subsidiary in New York from July 13-17, 2026, which identified one Form 483 observation but confirmed the company will address it within the required timeframe.

📄 View Original Announcement (PDF)

📊 Stock Analysis — CIPLA ✨ Ask AI About This

About Cipla Limited (CIPLA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,15,682.55 Cr P/E: 25.4 ROE: 14.6% ROCE: 19.4%

View full CIPLA stock details →

📡 Get AI alerts when CIPLA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CIPLA — Free

💡 Ask AI about this filing

"How will Cipla address the Form 483 observation?" "What is the expected timeline for resolution?" "How does this impact InvaGen's contribution to Cipla's overall revenue?"

Ask AI Free →

📊 More CIPLA filings

See all CIPLA filings →

🔥 Also filed on 18 July 2026

ICICIBANK ICICI Bank Limited Financial Results SHREYANIND Shreyans Industries Limited Corporate Action ROSSARI Rossari Biotech Limited Financial Results ROSSARI Rossari Biotech Limited Corporate Action MAPMYINDIA C.E. Info Systems Limited Annual Report CAMLINFINE Camlin Fine Sciences Limited Annual Report

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CIPLA files new disclosures

Track CIPLA filings, board meetings, and corporate actions. Free email alerts at 5 PM.